chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Insomnia, Myalgia, Somnolence
Clinical narrative: Pain made sleeping extremely difficult; significant pain in muscle between right shoulder and base of skull/severe pain in muscle between right shoulder and base of skull; significant pain in muscle between right shoulder and base of skull; sleepy; This is a spontaneous report from a contactable Other HCP.   A 71-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6203), via an unspecified route of administration in left arm on 04Mar2021 at 10:45 as a single dose for COVID-19 immunization. The patient's medical history included idiopathic grand mal epilepsy. The patient's concomitant medication included phenobarbital, primidone, phenytoin and atorvastatin. The patient did not receive any other vaccine in four weeks. The patient was not diagnosed with COVID prior vaccination. The patient had no known allergies. . On 04Mar2021 at 16:00 (Thursday), the patient experienced sleepy. On 05Mar2021 at evening (Friday), the patient experienced significant pain in muscle between left shoulder and base of skull and on 06Mar2021 (Saturday evening) experienced severe pain in muscle between right shoulder and base of skull and pain made sleeping extremely difficult. The patient received Motrin 800mg somewhat alleviated with pain. The patient did not undergo COVID test post vaccination. The outcome of the event was not resolved.  No follow up attempts are possible. No further information was expected.
Sex: M
Vaccine: COVID19
Symptoms: Rash, Swelling face
Clinical narrative: rash; facial swelling; This is a spontaneous report from a Pfizer Sponsored Program. A contactable consumer reported for a male patient (Father) that. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection,Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as UNKNOWN, SINGLE DOSE for covid-19 immunisation. The patient medical history, concomitant medications were not reported. Therapeutic measures were taken as a result of rash (rash), facial swelling (swelling face).Treated with Benadryl. On an unspecified date The patient experienced rash, facial swelling. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Erythema, Flushing, Nausea
Clinical narrative: fever; chills; nausea; face flushed; face flushed and is red; diarrhea; This is a spontaneous report from a contactable consumer(patient). A female patient of an unspecified age received first dose bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number and Expiration date was unknown), via an unspecified route of administration on 05Mar2021 13:00 as 1ST DOSE, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. 06Mar2021, her face flushed and is red but she felt ok. On 06Mar2021 evening, she started to have diarrhea. 07Mar2021 she had fever, chills, nausea, and diarrhea. She wanted to know if those are normal adverse events with the Pfizer COVID-19 vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever; chills; nausea; face flushed; face flushed and is red; diarrhea; This is a spontaneous report from a contactable consumer(patient). A female patient of an unspecified age received first dose bnt162b2 (BNT162B2, Formulation: solution for injection, Batch/Lot Number and Expiration date was unknown), via an unspecified route of administration on 05Mar2021 13:00 as 1ST DOSE, SINGLE for covid-19 immunization. The patient medical history was not reported. The patient's concomitant medications were not reported. 06Mar2021, her face flushed and is red but she felt ok. On 06Mar2021 evening, she started to have diarrhea. 07Mar2021 she had fever, chills, nausea, and diarrhea. She wanted to know if those are normal adverse events with the Pfizer COVID-19 vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Disturbance in attention, Dizziness, Dysgeusia, Headache
Clinical narrative: Chills; body aches; HA; rash (not uncomfortable); metallic taste; dizziness; difficulty focusing; This is a spontaneous report from a contactable consumer (patient). A 69-year-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported) via an unspecified route of administration, administered in arm left on 04Mar2021 at 16:15 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. Medical history included tetanus, known allergies: sulfa, red nail polish, and COVID prior vaccination. Concomitant medications included bupropion. The patient did not receive any other vaccine in four weeks. The patient previously took percocet (oxycodone hydrochloride; paracetamol) and linzess and experienced known allergies. Since the vaccination, the patient had not been tested for COVID-19. On 04Mar2021 at 18:30, the patient experienced chills, body aches, ha (headache), rash (not uncomfortable), metallic taste, dizziness and difficulty focusing. The patient did not receive any treatment for the events. The outcome of the events was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Rash
Clinical narrative: Chills; body aches; HA; rash (not uncomfortable); metallic taste; dizziness; difficulty focusing; This is a spontaneous report from a contactable consumer (patient). A 69-year-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported) via an unspecified route of administration, administered in arm left on 04Mar2021 at 16:15 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. Medical history included tetanus, known allergies: sulfa, red nail polish, and COVID prior vaccination. Concomitant medications included bupropion. The patient did not receive any other vaccine in four weeks. The patient previously took percocet (oxycodone hydrochloride; paracetamol) and linzess and experienced known allergies. Since the vaccination, the patient had not been tested for COVID-19. On 04Mar2021 at 18:30, the patient experienced chills, body aches, ha (headache), rash (not uncomfortable), metallic taste, dizziness and difficulty focusing. The patient did not receive any treatment for the events. The outcome of the events was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: bad headache; This is a spontaneous report received from a contactable consumer, the patient. A 72-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6198) via an unspecified route of administration, administered in left arm on 04Mar2021 at 09:15 AM as 1st dose, single dose for COVID-19 immunization. The patient's medical history included enlarged prostate. The patient had ox codene allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not been tested for COVID-19 post vaccination. The patient did not suffer from COVID prior vaccination. The patient's concomitant medications included simvastatin, dutasteride, famotidine (PEPCID) and (tamsulosin hydrochloride) FLOWMAX (in two weeks after vaccination). On 05Mar2021 at 03:00 AM, the patient woke up with bad headache. The patient took two paracetamol (TYLENOL) and headache went away in about 1 hour 30 minutes. Event recovered on 05Mar2021.   No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever of 100.4 Degree F and 100.6 Degree F; This is a spontaneous report from a contactable consumer (patient) via medical information team.  A 70-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), via an unspecified route of administration on 05Mar2021 (Batch/Lot number was not reported) as 1st dose, single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On 05Mar2021 the patient experienced fever of 100.4-degree F and on 06Mar2021, patient had 100.6-degree F. Patient wanted to know if she was contagious and also reported that her 30-year-old daughter was due to get the Pfizer vaccine and asked would she get any side effects from it. Patient queried if both doses are 0.3 and that if moderna covid vaccine have the same side effects. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Nausea, Pain, Pain in extremity
Clinical narrative: Fever; chills; arm ached; ached all over; felt faint; sick to my stomach; This is a spontaneous report from a contactable consumer or other non hcp (patient).     A 71-year-old (age at vaccination) non-pregnant (at the time of vaccination) female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Batch/Lot Number: unknown) via an unspecified route of administration, administered in left arm on 05Mar2021 at 11:30 as single dose for covid-19 immunization. Medical history included covid-19 in Jul2020 (prior vaccination), allergies with codeine and sulfur drugs. Concomitant medications included levothyroxine sodium (THYROXINE), omeprazole, estradiol (ESTROGEN), progesterone. The patient previously took codeine and experienced drug hypersensitivity. Patient not administered other vaccine in four weeks. Patient was not tested for Covid post vaccination. On 06Mar2021 at 04:00, after vaccination the patient experienced fever, chills, arm ached, ached all over, felt faint, sick to her stomach. The outcome of the events was resolving.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Fever; chills; arm ached; ached all over; felt faint; sick to my stomach; This is a spontaneous report from a contactable consumer or other non hcp (patient).     A 71-year-old (age at vaccination) non-pregnant (at the time of vaccination) female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Batch/Lot Number: unknown) via an unspecified route of administration, administered in left arm on 05Mar2021 at 11:30 as single dose for covid-19 immunization. Medical history included covid-19 in Jul2020 (prior vaccination), allergies with codeine and sulfur drugs. Concomitant medications included levothyroxine sodium (THYROXINE), omeprazole, estradiol (ESTROGEN), progesterone. The patient previously took codeine and experienced drug hypersensitivity. Patient not administered other vaccine in four weeks. Patient was not tested for Covid post vaccination. On 06Mar2021 at 04:00, after vaccination the patient experienced fever, chills, arm ached, ached all over, felt faint, sick to her stomach. The outcome of the events was resolving.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Pain
Clinical narrative: Fatigue; soreness; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 32-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6206), via an unspecified route of administration in left arm on 06Mar2021 at 04:15 PM (at 32 years of age) as single dose for covid-19 immunization. The patient medical history was not reported. The patient did not receive any other vaccine in four weeks of covid-19 vaccine. The patient did not have COVID prior to vaccination. Concomitant medications were not reported. On an unspecified date, the patient experienced fatigue and soreness. The patient was not tested for COVID post vaccination. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Tremor
Clinical narrative: Full body shaking, uncontrollable; intense shivering; jaw chattering; This is a spontaneous report from a contactable other health care professional (Patient). A 30-years-old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6026) via an unspecified route of administration, administered in Arm Left on 06Mar2021 at 15:00 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient did not receive other vaccine in four weeks. Patient did not have Covid prior vaccination. Patient did not tested Covid post vaccination. On 06Mar2021 at 19:00 the patient experienced full body shaking, uncontrollable, intense shivering, jaw chattering. All the events were considered as non-serious. events lasted on and off for one hour with different levels of severity. Took Tylenol and symptoms subsided. No other vaccine in four weeks. No Covid prior vaccination, no Covid tested post vaccination. No treatment. Patient was recovered from the events in March 2021.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: swelling and redness in her injection site; swelling and redness in her injection site; This is a spontaneous report from a contactable consumer reporting on behalf of a female patient.  A female patient of an unspecified age received an unspecified dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced swelling and redness at her (vaccination) injection site. To help with the discomfort, the reporter wanted to know if ice or warm application on the vaccination site can be done or Tylenol should be taken. The clinical outcome of the events was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Night sweats, Paraesthesia oral, Tongue disorder, Vaccination site pruritus
Clinical narrative: I started to get severe itching in the underside of the upper arm (left) the injection arm; There were hives present in that location only; I also felt tingling in my lips and a thick tongue; I also felt tingling in my lips and a thick tongue; I was tired for about 3 days after the injection; night sweats on the third night; This is a spontaneous report from a contactable nurse (patient). A 74-year-old female patient (non-pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL9266) via an unspecified route of administration, in left arm, on 23Feb2021 (at the age of 74 years) as a single dose for COVID-19 immunization at Hospital. The patient medical history included multiple sclerosis, hives. The patient had no history of known allergies. Concomitant medications included glatiramer acetate (COPAXONE), hydrochlorothiazide. Historical vaccine includes first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL9265) via an unspecified route of administration, in left arm on 02Feb2021 (at the age of 74 years) as a single dose for COVID-19 immunization. There were no other vaccines received in four weeks. Prior vaccination, the patient had no Covid. On 23Feb2021, 5 hours after receiving injection she started to get severe itching in the underside of the upper arm (left) the injection arm. There were hives present in that location only. She also felt tingling in lips and a thick tongue. she had an Epi-pen from previous hives (unknown origin) a few years ago. As she live only a mile from the hospital and she was a retired nurse, she just assessed the symptoms and kept the EpiPen by her side. After about an hour, the symptoms subsided. She was tired for about 3 days after the injection and had night sweats on the third night in Feb2021. There was no treatment received for the adverse events. Post vaccination, the patient was not tested for Covid. Outcome of the events was reported as recovered in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site urticaria
Clinical narrative: I started to get severe itching in the underside of the upper arm (left) the injection arm; There were hives present in that location only; I also felt tingling in my lips and a thick tongue; I also felt tingling in my lips and a thick tongue; I was tired for about 3 days after the injection; night sweats on the third night; This is a spontaneous report from a contactable nurse (patient). A 74-year-old female patient (non-pregnant) received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL9266) via an unspecified route of administration, in left arm, on 23Feb2021 (at the age of 74 years) as a single dose for COVID-19 immunization at Hospital. The patient medical history included multiple sclerosis, hives. The patient had no history of known allergies. Concomitant medications included glatiramer acetate (COPAXONE), hydrochlorothiazide. Historical vaccine includes first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL9265) via an unspecified route of administration, in left arm on 02Feb2021 (at the age of 74 years) as a single dose for COVID-19 immunization. There were no other vaccines received in four weeks. Prior vaccination, the patient had no Covid. On 23Feb2021, 5 hours after receiving injection she started to get severe itching in the underside of the upper arm (left) the injection arm. There were hives present in that location only. She also felt tingling in lips and a thick tongue. she had an Epi-pen from previous hives (unknown origin) a few years ago. As she live only a mile from the hospital and she was a retired nurse, she just assessed the symptoms and kept the EpiPen by her side. After about an hour, the symptoms subsided. She was tired for about 3 days after the injection and had night sweats on the third night in Feb2021. There was no treatment received for the adverse events. Post vaccination, the patient was not tested for Covid. Outcome of the events was reported as recovered in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Body mass index, Erythema, Oral disorder, Swelling, Swelling face
Clinical narrative: lower half of face including under chin and some of neck was red and swollen; some of neck was red and swollen; lower half of face including under chin and some of neck was red and swollen; unusual taste on tongue; roof of mouth bumpy; lower half of face including under chin and some of neck was red and swollen; This is a spontaneous report from a contactable consumer. A 69-years-old non-pregnant female patient received BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Lot Number: EN531005121), dose 1 via an unspecified route of administration, administered in left arm on 20Feb2021 13:00 as 1st dose, single for COVID-19 immunization. No other vaccine in four weeks. No covid prior vaccination. Medical history included TIA from May2020 and high blood pressure. Patient was allergic to penicillin, omeprazole, bactram, adhesives, gold, and other metals. Concomitant medication in two weeks of vaccination included 40 mg VALSARTAN and 81 mg ASPIRIN. On 20Feb2021 13:00, the patient experienced lower half of face including under chin and some of neck was red and swollen, unusual taste on tongue, roof of mouth bumpy. The patient underwent lab tests and procedures which included body mass index: 30. Patient went to Emergency room/department or urgent care as result of events. No covid tested post vaccination. Therapeutic measures were taken with BENADRYL 25 mg. Patient was recovered from events in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Taste disorder
Clinical narrative: lower half of face including under chin and some of neck was red and swollen; some of neck was red and swollen; lower half of face including under chin and some of neck was red and swollen; unusual taste on tongue; roof of mouth bumpy; lower half of face including under chin and some of neck was red and swollen; This is a spontaneous report from a contactable consumer. A 69-years-old non-pregnant female patient received BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Lot Number: EN531005121), dose 1 via an unspecified route of administration, administered in left arm on 20Feb2021 13:00 as 1st dose, single for COVID-19 immunization. No other vaccine in four weeks. No covid prior vaccination. Medical history included TIA from May2020 and high blood pressure. Patient was allergic to penicillin, omeprazole, bactram, adhesives, gold, and other metals. Concomitant medication in two weeks of vaccination included 40 mg VALSARTAN and 81 mg ASPIRIN. On 20Feb2021 13:00, the patient experienced lower half of face including under chin and some of neck was red and swollen, unusual taste on tongue, roof of mouth bumpy. The patient underwent lab tests and procedures which included body mass index: 30. Patient went to Emergency room/department or urgent care as result of events. No covid tested post vaccination. Therapeutic measures were taken with BENADRYL 25 mg. Patient was recovered from events in 2021.  No follow-up attempts are possible. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia, Peripheral coldness
Clinical narrative: The tingling became almost numb in my feet at 72 hours; After the second vaccine both my feet and hand became very cold and tingling; After the second vaccine both my feet and hand became very cold and tingling; This is a spontaneous report from a contactable consumer (patient). A 49-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: En6203), via an unspecified route, administered in Left arm on 03Mar2021 10:00 AM (at the age of 49-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included COVID-19 (prior to vaccination). Patient had no known allergies. The patient's concomitant medications were not reported. Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: El3248), via an unspecified route, administered in Left arm on 09Feb2021 at 04:45 PM (at the age of 49-year-old) as a single dose for COVID-19 immunisation. The patient had no other vaccination 4 weeks prior to Covid-19 vaccine. On 03Mar2021 at 06:00 PM (8 hours after the second vaccine), the patient experienced both her feet and hand became very cold and tingling. It has continued for four days - seemed to be worse at 72 hours and was hopefully improving on day 4. The tingling became almost numb in her feet at 72 hours (on 06Mar2021 at 10:00). She never had a feeling like this before. The patient had not tested for Covid-19 post vaccination. The patient had not received any treatment for the resulted events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information was expected.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Influenza like illness, Pyrexia, SARS-CoV-2 test
Clinical narrative: Flu like symptoms; joint pain; low grade fever; chills; This is a spontaneous report received from a contactable consumer (Patient). This 42-year-old female non pregnant patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; formulation: Solution for injection; Lot Number and expiry date was not reported), via an unspecified route administration on left arm on 06Mar2021 14:15 as a 1st dose single for COVID-19 immunisation. Medical history included uveitis and Covid-19 (prior vaccination). Concomitant medication included esomeprazole magnesium (NEXIUM) received within two weeks of vaccination. The patient had COVID prior vaccination, and patient was tested for COVID post vaccination. The patient underwent nasal swab test on 22Feb2021 and on 27Feb2021 and the test result were negative. The patient had no known allergies. On 06Mar2021 15:30, the patient experienced Flu like symptoms, joint pain, low grade fever and chills. Patient did not receive any treatment for the events. The outcome of the events was not recovered.   No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: aches; feeling feverish; This is a spontaneous report from a contactable consumer or other non healthcare professional. A 68-years-old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Left on 06Mar2021 17:00 (Batch/Lot Number: EN6199) as SINGLE DOSE for covid-19 immunisation Medical history included pace maker, high blood pressure and macular D. The patient known allergies included tomatoes. The patient experienced aches and feeling feverish on 07Mar2021. Outcome of the events recovering.  No follow-up attempts are possible. No further information is expected.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Back pain, Pain
Clinical narrative: moderate pain that basically encircled my body just above the hips; back pain; abdominal pain; This is a spontaneous report from a contactable consumer (patient). A 69-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EM9809), via an unspecified route of administration on 25Feb2021 at 12:00 PM (at the age of 69-year-old) as a 1st dose, single dose for COVID-19 immunisation. The patient's medical history included allergies: yes, antibiotics. The patient's concomitant medications were not reported. No other vaccine in four weeks. No covid prior vaccination and no covid tested post vaccination. On 25Feb2021 17:00, the patient stated that, he didn't know if it's related or not, but later on the day of the first vaccine shot he started to experience moderate pain that basically encircled his body just above the hips. After 3 or 4 days the back pain lessened somewhat. Today, 10 days after the vaccine the patient still had some back and abdominal pain in that area. The patient was concerned that the second shot would have the same effect. Has pain in the area above the hips been reported by others or not. Treatment was not received for the events. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Body temperature, Cold sweat, Pyrexia
Clinical narrative: stomach pain; cold sweat; fever; This is a spontaneous report from a contactable consumer. A 71-year- old male consumer (patient) received second dose of bnt162b2 (BNT162B2, Solution for injection, Lot number: EM9809) via unspecified route of administration on 24Feb2021 04:45 PM as single dose in right arm for COVID-19 immunization. No medical history reported. Concomitant medications reported was lisinopril (ZESTRIL), simvastatin and acetylsalicylic acid (BABY ASPIRIN). Patient has not received any other vaccine in four weeks. No covid prior vaccination and post vaccination was reported. No known allergies were reported. Patient previously took BNT162B2 first dose on 03Feb2021 on 04:45 PM in right arm. After 2nd dose, 8 days later, developed stomach pain and cold sweat that lasted the night. The next morning had fever of 102. Next day 101.8. To say 101.2 and now 99.6. No treatment was received as response to the event. Outcome of the event was fever recovering and for other events its not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Injection site pain, Migraine, Paraesthesia
Clinical narrative: Pain at inoculation site; tingling down inoculated arm; migraine headache; fever (low grade); rash on arms and legs; severe fatigue; chills (minor); This is a spontaneous report from a contactable consumer. A 66-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) (Batch no: EN6200) via an unspecified route of administration at left arm on 02Mar2021 08:00 as a single dose for covid-19 immunisation. The patient's medical history includes Fibromyalgia and Marfan Syndrome, known allergies: Sulfa drugs and wasp stings. Patient took first dose of vaccine on product COVID 19 immunisation Lot number: EL9263, administration on 03Feb2021, 06:00 PM, at Left arm. Concomitant medications includes Proscar, Cymbalta, Klonopin, Neurontin. On 02Mar2021 at 06:15 PM the patient experienced the following events took place after receiving the first and second doses, but definitely harsher and more defined after the second dose. Pain at inoculation site, tingling down inoculated arm, migraine headache, fever (low grade), rash on arms and legs, severe fatigue, chills (minor). Patient didn't receive any treatment for the events. Outcome of all events was resolved on an unspecified date in 2021.  No follow up attempts are possible. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: Pain at inoculation site; tingling down inoculated arm; migraine headache; fever (low grade); rash on arms and legs; severe fatigue; chills (minor); This is a spontaneous report from a contactable consumer. A 66-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection) (Batch no: EN6200) via an unspecified route of administration at left arm on 02Mar2021 08:00 as a single dose for covid-19 immunisation. The patient's medical history includes Fibromyalgia and Marfan Syndrome, known allergies: Sulfa drugs and wasp stings. Patient took first dose of vaccine on product COVID 19 immunisation Lot number: EL9263, administration on 03Feb2021, 06:00 PM, at Left arm. Concomitant medications includes Proscar, Cymbalta, Klonopin, Neurontin. On 02Mar2021 at 06:15 PM the patient experienced the following events took place after receiving the first and second doses, but definitely harsher and more defined after the second dose. Pain at inoculation site, tingling down inoculated arm, migraine headache, fever (low grade), rash on arms and legs, severe fatigue, chills (minor). Patient didn't receive any treatment for the events. Outcome of all events was resolved on an unspecified date in 2021.  No follow up attempts are possible. No further information is expected.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Nasopharyngitis, Seasonal allergy
Clinical narrative: patient had a head cold since the day after his shot. The Dr. said it was allergies; patient had a head cold since the day after his shot. The Dr. said it was allergies; This is spontaneous report from a contactable consumer (patient). A 71-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot Number: Unknown), via unspecified route of administration on left arm on 19Feb2021 at 12:00 AM (at the age of 71-year-old)  as a 2ND DOSE, SINGLE DOSE for covid-19 immunization. Patient had known allergies with quinine and other medical history included diabetes and heart. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: Solution for injection, Batch/Lot Number: Unknown), via unspecified route of administration on left arm on 29Jan2021 at 12:00 AM as a 1ST DOSE, SINGLE DOSE for covid-19 immunization. Other medications received by the patient in two weeks were 6 daily prescription medicines. Patient did not receive other vaccine in four weeks prior to the vaccination and not diagnosed with covid prior vaccination. On 20Feb2021 at 12:00 AM, patient had a head cold since the day after his shot. The Dr. said it was allergies. He took benadryl, no better then switched to Tylenol for colds. He still was not better. He was only allowed to take certain over the counter meds because of his heart. Events resulted in doctor or other health care professional office/clinic visit. Patient did not receive any treatment for allergies. Patient did not test for covid post vaccination. Outcome of both the events were not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Movement disorder, Vertigo
Clinical narrative: extreme vertigo; unable to move head or body without vertigo worsening; This is a spontaneous report from a contactable consumer (Patient). A 73-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered in Arm Left on 28Feb2021 as 1st dose, single dose for covid-19 immunisation (at the age of 73-year-old). Medical history included hypertension, chronic lymphocytic leukaemia, prostate cancer, malignant melanoma and blood pressure abnormal. Concomitant medication included BP medications (unspecified) in two weeks. Patient did not receive any other vaccine in four weeks. Patient no covid prior vaccination. No covid tested post vaccination. No known allergies reported. On 28Feb2021, the patient experienced extreme vertigo and unable to move head or body without vertigo worsening. Patient did not receive any treatment for events. The outcome of event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Decreased appetite, Dyspnoea, Fatigue, Feeling abnormal
Clinical narrative: Shortness of breath; Weakness; fatigue; loss of appetite; feeling in a daze; This is a spontaneous report from a contactable consumer (patient). A 66-year-old non pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EN6206), via unspecified route of administration in the right arm (at the age of 66-year-old) on 06Mar2021 at 14:00 as single dose for COVID-19 immunisation. Medical history included COVID (prior vaccination). It was reported that the patient had no allergies. Concomitant medications were not reported. The patient was not pregnant at the time of vaccination. On 07Mar2021, the patient experienced shortness of breath, weakness, fatigue, loss of appetite and feeling in a daze. The patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19 on an unspecified date. The patient was not tested for COVID post vaccination. The patient did not received treatment for events. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dysphonia, Ear pruritus, Hyperhidrosis, Lacrimation increased
Clinical narrative: I developed a sore throat; hoarseness; chilled; sweaty; My eyes were watery; nose started running; My ears were itchy; This is a spontaneous report from a contactable Nurse (patient). A 63-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm Right on 06Mar2021 13:00 (Batch/Lot Number: EN6207) as single dose for COVID-19 immunisation. Medical history included asthma. The patient's concomitant medications were not reported. The patient previously took benzocaine and experienced anaphylactic reaction, took first dose of BNT162B2 for COVID-19 immunisation. The patient received no other vaccination in four weeks. On 06Mar2021 at 13.15, within 10 mins of receiving 2nd injection (as reported), the patient developed a sore throat and hoarseness. She became chilled, then sweaty. Her eyes were watery and her nose started running. Her ears were itchy. The patient received treatment with 25 mg Benadryl by Medic. No Covid prior vaccination and no Covid tested post vaccination. Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Rhinorrhoea
Clinical narrative: I developed a sore throat; hoarseness; chilled; sweaty; My eyes were watery; nose started running; My ears were itchy; This is a spontaneous report from a contactable Nurse (patient). A 63-years-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration, administered in Arm Right on 06Mar2021 13:00 (Batch/Lot Number: EN6207) as single dose for COVID-19 immunisation. Medical history included asthma. The patient's concomitant medications were not reported. The patient previously took benzocaine and experienced anaphylactic reaction, took first dose of BNT162B2 for COVID-19 immunisation. The patient received no other vaccination in four weeks. On 06Mar2021 at 13.15, within 10 mins of receiving 2nd injection (as reported), the patient developed a sore throat and hoarseness. She became chilled, then sweaty. Her eyes were watery and her nose started running. Her ears were itchy. The patient received treatment with 25 mg Benadryl by Medic. No Covid prior vaccination and no Covid tested post vaccination. Outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: pretty sick Friday and Saturday; This is a spontaneous report from a contactable female consumer (reported for herself). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for Injection, Batch/Lot number was not reported), via an unspecified route of administration on 04Mar2021 at a 1st dose, single dose for COVID-19 immunization. Medical history included arthritis (patient takes Aleve, occasionally, for arthritis). Concomitant medication included naproxen sodium (ALEVE) taken for arthritis. Reporter is a patient who received her first dose of Pfizer-Biontech Covid19 vaccine this past Thursday, 04Mar2021. Patient takes Aleve, occasionally, for arthritis. Patient needs to wait a week after vaccination before she can take anything like Aleve, per the CDC website. The patient experienced pretty sick Friday and Saturday on an unspecified date in 2021. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: mild arm soreness; This is a spontaneous report from a contactable consumer (patient). A 75-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient's medical history included allergy to sulfa. The patient's concomitant medications were not reported. On an unspecified date, the patient experienced mild arm soreness. The outcome of the event was unknown.  No Follow-up attempts are possible. Information about lot/batch cannot be obtained.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site rash
Clinical narrative: Redness/rash at injection site/appears as a splotchy red; Redness/rash at injection site/appears as a splotchy red; This is a spontaneous report from a contactable consumer (patient). A 36-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; solution for injection, Lot Number and Expiration date: Unknown), via an unspecified route of administration in left arm on 05Mar2021 at 11:00 (at the age of 36-year-old) as 1st dose, single dose for COVID-19 vaccination. Medical history included Eczema, full thyroidectomy, right neck dissection to remove lymph nodes (Neck dissection), right neck dissection to remove lymph nodes (Lymph node excision) and papillary thyroid cancer from an unknown date in Nov2018 to unknown date and unknown if going. Concomitant medication included levothyroxine sodium (SYNTHROID), Kaitilib (Birth Control Pill), Vitamin. Patient previously took Ceclor drug and experienced allergy. Not received other vaccine in four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Mar2021, after 48 hours from vaccination, the patient experienced Redness/rash at injection site. Rash was not itchy or raised and appears as a splotchy red. Patient was treated with antihistamine for events. The outcome of the events was Recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Ear discomfort, Heart rate, Heart rate increased, Hypertension
Clinical narrative: High heart rate; high blood pressure; swollen tongue; trip to the Ear for observation; This is a spontaneous report from a contactable consumer (patient).   A 44-years-old non-pregnant female patient received first dose of BNT162B2(Formulation: Solution for injection; Batch/Lot number: unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 07Mar2021 09:00 AM (at the age of 44 years) as 1ST DOSE SINGLE for covid-19 immunisation. Medical history included multiple sclerosis from an unknown date and unknown if ongoing. Known allergies with Stevia, penicillin, and sulfa sclerosis from an unknown date and unknown if ongoing. Concomitant medication included naltrexone (NALTREXONE) 3 mg taken for an unspecified indication, start and stop date were not reported. On 07Mar2021 09:15 AM patient experienced high heart rate, high blood pressure, swollen tongue and trip to the Ear for observation. 25 mg of benedryl given orally and released an hour later. The events resulted in doctor or other healthcare professional office/clinic visit since the vaccination, patient has not been tested for covid-19. The outcome of the events was resolving.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Swollen tongue
Clinical narrative: High heart rate; high blood pressure; swollen tongue; trip to the Ear for observation; This is a spontaneous report from a contactable consumer (patient).   A 44-years-old non-pregnant female patient received first dose of BNT162B2(Formulation: Solution for injection; Batch/Lot number: unknown), dose 1 via an unspecified route of administration, administered in Arm Left on 07Mar2021 09:00 AM (at the age of 44 years) as 1ST DOSE SINGLE for covid-19 immunisation. Medical history included multiple sclerosis from an unknown date and unknown if ongoing. Known allergies with Stevia, penicillin, and sulfa sclerosis from an unknown date and unknown if ongoing. Concomitant medication included naltrexone (NALTREXONE) 3 mg taken for an unspecified indication, start and stop date were not reported. On 07Mar2021 09:15 AM patient experienced high heart rate, high blood pressure, swollen tongue and trip to the Ear for observation. 25 mg of benedryl given orally and released an hour later. The events resulted in doctor or other healthcare professional office/clinic visit since the vaccination, patient has not been tested for covid-19. The outcome of the events was resolving.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain
Clinical narrative: Extreme pain on left side of body knee, ankle, hipt side of body knee, angle, hip; Extreme pain on left side of body knee, ankle, hip side of body knee, ankle, hip; This is a spontaneous report received from a contactable consumer (Patient). A 76-year-old female patient received first dose of BNT162B2(PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, expiry date: unknown), via an unspecified route of administration, administered in Arm Left on 01Mar2021 at 10:45 as 1st dose, single dose for covid-19 immunisation. Patient medical history included torn meniscus injury left knee. Patient concomitant medication included Tramadol (50mg), Gabapentin (300mg). Patient was not allergic. The patient was not diagnosed with COVID-19 prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 01Mar2021 at 16:00, the patient experienced extreme pain on left side of body knee, ankle, hip it had lasted 6 days already and not letting up. No treatment was received. The outcome pf event was not recovered.  No follow-up attempts are needed. Information about lot/batch number cannot be obtained.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia, Peripheral swelling, Pruritus, Pyrexia
Clinical narrative: Arm tingle a few minutes after 2nd vaccine; Next day sore arm; 100.8 fever/ Fever lasted 12 hours; Then itchy and swollen arm end of day 3; Then itchy and swollen arm end of day 3; This is a spontaneous report from a non-contactable consumer (patient). A 54-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number and expiry date were not provided), via an unspecified route of administration in left arm on 03Mar2021 at 15:30 (at the age of 54-years-old) as a single dose for covid-19 immunisation. Patient had known allergy to neomycin. Medical history included chronic venous insufficiency (CVI) and lymphedema. Concomitant medication included apixaban (ELIQUIS) and acetylsalicylic acid (ASPIRIN). Patient did not receive other vaccine in four weeks of vaccination. Other medication in two weeks included apixaban (ELIQUIS) and acetylsalicylic acid (ASPIRIN). Patient was not diagnosed with COVID, prior vaccination. Patient has not been tested for COVID, post vaccination. Patient had previously received first dose of vaccine in left arm on 09Feb2021. On 04Mar2021 at 12:00, arm tingle a few minutes after 2nd vaccine. Next day sore arm and 100.8 fever lasted 12 hours. Then itchy and swollen arm end of day 3. Need a Benadryl. No treatment was received. The outcome of all events was recovering.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.